Voyager Therapeutics, Inc. (VYGR) — Revenue

Annual figures by fiscal year, from SEC filings.

2016: $14.22M2017: $10.13M2018: $7.62M2019: $104.39M2020: $171.13M2021: $37.41M2022: $40.91M2023: $250.01M2024: $80.00M2025: $40.37M$40.37M
2016Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$40.37M-49.5%
2024$80.00M-68.0%
2023$250.01M+511.2%
2022$40.91M+9.3%
2021$37.41M-78.1%
2020$171.13M+63.9%
2019$104.39M+1270.1%
2018$7.62M-24.8%
2017$10.13M-28.7%
2016$14.22M